Known susceptibility SNPs for sporadic prostate cancer show a similar association with "Hereditary" prostate cancer

Prostate

Volumn 75, Issue 5, 2015, Pages 474-483

  Cremers, Ruben G ^a,b   Galesloot, Tessel E ^a   Aben, Katja K ^a,c   Van Oort, Inge M ^a   Vasen, Hans F ^b   Vermeulen, Sita H ^a   Kiemeney, Lambertus A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Foundation for the Detection of Hereditary Tumours   (Netherlands)

^c Department of Cancer Registry and Research   (Netherlands)

Author keywords

Association; Genetics; Risk score; Single nucleotide polymorphism

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FAMILIAL CANCER; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITARY PROSTATE CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; SINGLE NUCLEOTIDE POLYMORPHISM; SPORADIC PROSTATE CANCER; VERY ELDERLY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NETHERLANDS; PROSTATE TUMOR; RISK FACTOR; STATISTICAL MODEL;

AGED; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS; ROC CURVE;

EID: 84923419840     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22933     Document Type: Article

References (26)

1. Bolla M, Poppel Hv. Management of prostate cancer: A multidisciplinary approach. Berlin: Springer 2012; viii: pp. 338.
2. Fletcher O, Houlston RS. Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 2010; 10(5):353-361.
3. Varghese JS, Easton DF. Genome-wide association studies in common cancers-what have we learnt. Curr Opin Genet Dev 2010; 20(3):201-209.
4. Witte JS. Prostate cancer genomics: Towards a new understanding. Nat Rev Genet 2009; 10(2)77-82.
5. Eeles RA, Kote-Jarai Z, Giles G.G., Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert D.A., Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL, Collaborators UKGPCS, British Association of Urological Surgeons' Section of O, Collaborators UKPS, Horwich A, Huddart RA, Khoo VS, Parker CC, Wood-house CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jamieson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008; 40(3):316-321.
6. Carter BS, Bova GS, Beaty T.H., Steinberg GD, Childs B, Isaacs WB, Walsh PC. Hereditary prostate cancer: Epidemiologic and clinical features. J Urol 1993; 150(3):797-802.
7. Langeberg WJ, Isaacs WB, Stanford JL. Genetic etiology of hereditary prostate cancer. Front Biosci 2007; 12:4101-4110.
8. Kiemeney LA, Broeders MJ, Pelger M, Kil P.J., Schroder FH, Witjes JA, Vasen HF. Screening for prostate cancer in Dutch hereditary prostate cancer families. Int J Cancer 2008; 122-(4):871-876.
9. Bratt O, Garmo H, Adolfsson J., Bill-Axelson A, Holmberg L, Lambe M., Stattin P. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates. J Natl Cancer Inst 2010; 102(17):1336-1343.
10. Eeles RA, Olama AA, Benlloch S, Saunders E.J., Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C., Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Roder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC, Initiative CO-CRUGE, Australian Prostate Cancer B, Oncology UKGPCSCBAoUSSo, Collaborators UKPS, Consortium P, Kote-Jarai Z, Easton DF. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013; 45(4):385-391.
11. Teerlink CC, Thibodeau SN, McDonnell S.K., Schaid DJ, Rinckleb A, Maier C, Vogel W., Cancel-Tassin G, Egrot C, Cussenot O, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Fitzgerald LM, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Wahlfors T, Tammela T, Schleutker J, Wiklund F, Gronberg H, Emanuelsson M, Carpten J, Bailey-Wilson J, Whittemore AS, Oakley-Girvan I, Hsieh CL, Catalona WJ, Zheng SL, Jin G, Lu L, Xu J, International Consortium for Prostate Cancer G, Camp NJ, Cannon-Albright LA. Association analysis of 9560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease. Hum Genet 2014; 133(3):347-356.
12. Gudmundsson J, Sulem P, Gudbjartsson D.F., Blondal T., Gylfason A, Agnarsson BA, Benediktsdottir K.R., Magnusdottir DN, Orlygsdottir G, Jakobsdottir M, Stacey SN, Sigurdsson A, Wahlfors T, Tammela T, Breyer JP, McReynolds KM, Bradley KM, Saez B, Godino J, Navarrete S, Fuertes F, Murillo L, Polo E, Aben KK, van Oort IM, Suarez BK, Helfand BT, Kan D, Zanon C, Frigge ML, Kristjansson K, Gulcher JR, Einarsson GV, Jonsson E, Catalona WJ, Mayordomo JI, Kiemeney LA, Smith JR, Schleutker J, Barkardottir RB, Kong A, Thorsteinsdottir U, Rafnar T, Stefansson K. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 2009; 41(10):1122-1126.
13. Meulenbeld HJ, Verhage BA, Kil P.J., Kiemeney LA, Vasen HF. [Characterisation of families with hereditary prostate cancer in the Netherlands]. Ned Tijdschr Geneeskd 2002; 146(41):1938-1942.
14. D'Amico AV, Whittington R, Malkowicz S.B., Cote K., Loffredo M, Schultz D, Chen M.H., Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 2002; 95(2):281-286.
15. Hoogendoorn EH, Hermus AR, de Vegt F, Ross HA, Verbeek A.L., Kiemeney LA, Swinkels DW, Sweep FC, den Heijer M. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: Influences of age and sex. Clin Chem 2006; 52(1):104-111.
16. Kiemeney LA, Thorlacius S, Sulem P., Geller F, Aben KK, Stacey S.N., Gudmundsson J., Jakobsdottir M, Bergthorsson JT, Sigurdsson A, Blondal T, Witjes JA, Vermeulen SH, Hulsbergen-van de Kaa, Swinkels CA, Ploeg DW, Cornel M, Vergunst EB, Thorgeirsson H, Gudbjartsson TE, Gudjonsson D, Thorleifsson SA, Kristinsson G, Mouy KT, Snorradottir M, Placidi S, Campagna D, Arici M, Koppova C, Gurzau K, Rudnai E, Kellen P, Polidoro E, Guarrera S, Sacerdote S, Sanchez C, Saez M, Valdivia B, Ryk G, de Verdier C, Lindblom P, Golka A, Bishop K, Knowles DT, Nikulasson MA, Petursdottir S, Jonsson V, Geirsson E, Kristjansson G, Mayordomo B, Steineck JI, Porru G, Buntinx S, Zeegers F, Fletcher MP, Kumar T, Matullo R, Vineis G, Kiltie P, Gulcher AE, Thorsteinsdottir JR, Kong U, Rafnar A, Stefansson T. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 2008; 40(11):1307-1312.
17. Kutyavin IV, Milesi D, Belousov Y., Podyminogin M, Vorobiev A, Gorn V., Lukhtanov EA, Vermeulen NM, Mahoney W. A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res 2006; 34(19):e128.
18. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genomewide association studies. PLoS Genet 2009; 5(6):e1000529.
19. Al Olama AA, Kote-Jarai Z, Berndt S.I., Conti DV, Schumacher F, Han Y, Benlloch S., Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, Stram DO, Rand K, Wan P, Stram A, Sheng X, Pooler LC, Park K, Xia L, Tyrer J, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Goh C, Ahmed M, Govindasami K, Guy M, Tammela TL, Auvinen A, Wahlfors T, Schleutker J, Visakorpi T, Leinonen KA, Xu J, Aly M, Donovan J, Travis RC, Key TJ, Siddiq A, Canzian F, Khaw KT, Takahashi A, Kubo M, Pharoah P, Pashayan N, Weischer M, Nordestgaard BG, Nielsen SF, Klarskov P, Roder MA, Iversen P, Thibodeau SN, McDonnell SK, Schaid DJ, Stanford JL, Kolb S, Holt S, Knudsen B, Coll AH, Gapstur SM, Diver WR, Stevens VL, Maier C, Luedeke M, Herkommer K, Rinckleb AE, Strom SS, Pettaway C, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, Cannon-Albright L, Cybulski C, Wokolorczyk D, Kluzniak W, Park J, Sellers T, Lin HY, Isaacs WB, Partin AW, Brenner H, Dieffenbach AK, Stegmaier C, Chen C, Giovannucci EL. A meta-analysis of 87, 040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet 2014; 46(10):1103-1109.
20. Purcell S, Neale B, Todd-Brown K, Thomas L., Ferreira MA, Bender D, Maller J, Sklar P., de Bakker PI, Daly MJ, Sham PC. PLINK: A tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet 2007; 81(3):559-575.
21. Burgess S, Thompson SG. Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol 2013; 42(4):1134-1144.
22. Gronberg H, Damber L, Tavelin B., Damber JE. No difference in survival between sporadic, familial and hereditary prostate cancer. Br J Urol 1998; 82(4):564-567.
23. Sacco E, Prayer-Galetti T, Pinto F., Ciaccia M, Fracalanza S, Betto G., Pagano F. Familial and hereditary prostate cancer by definition in an italian surgical series: clinical features and outcome. Eur Urol 2005; 47(6):761-768.
24. Gronberg H. Prostate cancer epidemiology. Lancet 2003; 361-(9360):859-864.
25. Ewing CM, Ray AM, Lange E.M., Zuhlke KA, Robbins CM, Tembe WD, Wiley K.E., Isaacs SD, Johng D, Wang Y, Bizon C, Yan G, Gielzak M, Partin AW, Shanmugam V, Izatt T, Sinari S, Craig DW, Zheng SL, Walsh PC, Montie JE, Xu J, Carpten JD, Isaacs WB, Cooney KA. Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med 2012; 366(2):141-149.
26. Bancroft EK, Page EC, Castro E, Lilja H., Vickers A, Sjoberg D, Assel M., Foster CS, Mitchell G, Drew K, Maehle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Selkirk C, Hulick PJ, Bojesen A, Skytte AB, Lam J, Taylor L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Blanco I, Salinas M, Cook J, Rosario DJ, Buys S, Conner T, Ausems MG, Ong KR, Hoffman J, Domchek S, Powers J, Teixeira MR, Maia S, Foulkes WD, Taherian N, Ruijs M, den Enden AT, Izatt L, Davidson R, Adank MA, Walker L, Schmutzler R, Tucker K, Kirk J, Hodgson S, Harris M, Douglas F, Lindeman GJ, Zgajnar J, Tischkowitz M, Clowes VE, Susman R, Ramon YCT, Patcher N, Gadea N, Spigelman A, van Os T, Liljegren A, Side L, Brewer C, Brady AF, Donaldson A, Stefansdottir V, Friedman E, Chen-Shtoyerman R, Amor DJ, Copakova L, Barwell J, Giri VN, Murthy V, Nicolai N, Teo SH, Greenhalgh L, Strom S, Henderson A, McGrath J, Gallagher D, Aaronson N, Ardern-Jones A, Bangma C, Dearnaley D, Costello P, Eyfjord J, Rothwell J, Falconer A, Gronberg H, Hamdy FC. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT Study. Eur Urol 2014; 66(3): 489-499.